Sfoglia per AUTORE
MOTTA M
Collezione ASL Vercelli

  

Items : 2

Minimal residual disease-driven treatment intensification with sequential addition of ibrutinib to venetoclax in R/R CLL. in Blood / Blood. 2022 Dec 1;140(22):2348-2357. doi: 10.1182/blood.2022016901.

2022
ASL Vercelli
AOU Città della Salute di Torino
AOU Alessandria
AOU Novara

Moia R; Scarfò L; Ghia P; Perotta E; Heltai S; Albi E; Scarano E; Schiattone L; Farina L; Ranghetti P; Colia M; Capasso A; Varettoni M; Coscia M; Rivela P; Laurenti L; Ferrario A; Motta M; Sancetta R; Reda G; Deodato M;

Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL. in Journal of hematology & oncology / J Hematol Oncol. 2022 Aug 26;15(1):116. doi: 10.1186/s13045-022-01333-0.

2022
AO Cuneo
ASL Vercelli
ASL Cuneo 1
AOU Alessandria

Ghia P; Stamatopoulos K; Yassin M; Coscia M; Rambaldi A; Montserrat E; Foà R; Cuneo A; Carrier M; Wróbel T; Segundo LYS; Varettoni M; Visentin A; Vitale C; Vukovic V; Shrestha A; Šimkovi? M; Smirnova S; Špa?ek M; Sportoletti P; Stanca O; Wasik-Szczepanek E; Stavroyianni N; Te Raa D; Tomic K; Tonino S; Trentin L; Van Der Spek E; van Gelder M; et alii...